MesoTV | Precision medicine and targeted therapies for mesothelioma with Dr. Hedy Kindler
Dr. Hedy Kindler of the University of Chicago Medicine joins us to discuss precision medicine and targeted therapies for the treatment of mesothelioma. Dr. Kindler explains the mechanisms of action for several molecular pathways associated with tumor growth and/or inhibition. She also discusses three specific therapeutic options available through clinical trials like CPI-0209 and olaparib (PARP inhibitors) targeted at the BAP1 tumor mutation; and the VT3989 targeting the NF2 pathway.
While these treatment options are still in early clinical trial phases, they target specific known tumor mutations, which makes them more precise than traditional chemotherapy treatment.
Watch video MesoTV | Precision medicine and targeted therapies for mesothelioma with Dr. Hedy Kindler online without registration, duration hours minute second in high quality. This video was added by user Mesothelioma Applied Research Foundation 23 February 2022, don't forget to share it with your friends and acquaintances, it has been viewed on our site 381 once and liked it 15 people.